Literature DB >> 28007647

Rewiring the spinal cord: Direct and indirect strategies.

Maria Teresa Dell'Anno1, Stephen M Strittmatter2.   

Abstract

Spinal cord injury is currently incurable. Treatment is limited to minimizing secondary complications and maximizing residual function by rehabilitation. Neurologic recovery is prevented by the poor intrinsic regenerative capacity of neurons in the adult central nervous system and by the presence of growth inhibitors in the adult brain and spinal cord. Here we identify three approaches to rewire the spinal cord after injury: axonal regeneration (direct endogenous reconnection), axonal sprouting (indirect endogenous reconnection) and neural stem cell transplantation (indirect exogenous reconnection). Regeneration and sprouting of axonal fibers can be both enhanced through the neutralization of myelin- and extracellular matrix-associated inhibitors described in the first part of this review. Alternatively, in the second part we focus on the formation of a novel circuit through the grafting of neural stem cells in the lesion site. Transplanted neural stem cells differentiate in vivo into neurons and glial cells which form an intermediate station between the rostral and caudal segment of the recipient spinal cord. In particular, here we describe how neural stem cells-derived neurons are endowed with the ability to extend long-distance axons to regain the transmission of motor and sensory information.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 28007647      PMCID: PMC5466898          DOI: 10.1016/j.neulet.2016.12.002

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  150 in total

Review 1.  Chondroitin sulphate proteoglycans in the central nervous system: changes and synthesis after injury.

Authors:  F Properzi; R A Asher; J W Fawcett
Journal:  Biochem Soc Trans       Date:  2003-04       Impact factor: 5.407

2.  Axons from CNS neurons regenerate into PNS grafts.

Authors:  P M Richardson; U M McGuinness; A J Aguayo
Journal:  Nature       Date:  1980-03-20       Impact factor: 49.962

3.  Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors.

Authors:  Daniel Fisher; Bin Xing; John Dill; Hui Li; Hai Hiep Hoang; Zhenze Zhao; Xiao-Li Yang; Robert Bachoo; Stephen Cannon; Frank M Longo; Morgan Sheng; Jerry Silver; Shuxin Li
Journal:  J Neurosci       Date:  2011-10-05       Impact factor: 6.167

4.  Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture.

Authors:  Yirui Sun; Steven Pollard; Luciano Conti; Mauro Toselli; Gerardo Biella; Georgina Parkin; Lionel Willatt; Anna Falk; Elena Cattaneo; Austin Smith
Journal:  Mol Cell Neurosci       Date:  2008-03-18       Impact factor: 4.314

5.  PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration.

Authors:  Yingjie Shen; Alan P Tenney; Sarah A Busch; Kevin P Horn; Fernando X Cuascut; Kai Liu; Zhigang He; Jerry Silver; John G Flanagan
Journal:  Science       Date:  2009-10-15       Impact factor: 47.728

6.  The oligodendrocyte-myelin glycoprotein gene is highly expressed during the late stages of myelination in the rat central nervous system.

Authors:  Patrick Vourc'h; Sabine Dessay; Olivier Mbarek; Sylviane Marouillat Védrine; Jean-Pierre Müh; Christian Andres
Journal:  Brain Res Dev Brain Res       Date:  2003-09-10

7.  The N-terminal domain of Nogo-A inhibits cell adhesion and axonal outgrowth by an integrin-specific mechanism.

Authors:  Fenghua Hu; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2008-01-30       Impact factor: 6.167

8.  Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact.

Authors:  Xingxing Wang; Soo-Jin Chun; Helen Treloar; Timothy Vartanian; Charles A Greer; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

9.  Targeting axon growth from neuronal transplants along preformed guidance pathways in the adult CNS.

Authors:  Kristine S Ziemba; Nagarathnamma Chaudhry; Alexander G Rabchevsky; Ying Jin; George M Smith
Journal:  J Neurosci       Date:  2008-01-09       Impact factor: 6.167

10.  Erasure of fear memories is prevented by Nogo Receptor 1 in adulthood.

Authors:  S M Bhagat; S S Butler; J R Taylor; B S McEwen; S M Strittmatter
Journal:  Mol Psychiatry       Date:  2015-12-01       Impact factor: 15.992

View more
  10 in total

1.  Plexina2 and CRMP2 Signaling Complex Is Activated by Nogo-A-Liganded Ngr1 to Restrict Corticospinal Axon Sprouting after Trauma.

Authors:  Yuichi Sekine; Percy T Algarate; William B J Cafferty; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2019-02-25       Impact factor: 6.167

2.  Enhanced axonal transport: A novel form of "plasticity" after primate and rodent spinal cord injury.

Authors:  J H Brock; E S Rosenzweig; H Yang; M H Tuszynski
Journal:  Exp Neurol       Date:  2017-12-22       Impact factor: 5.330

3.  Neurosurgical untethering with or without syrinx drainage results in high patient satisfaction and favorable clinical outcome in post-traumatic myelopathy patients.

Authors:  Ulrika Holmström; Parmenion P Tsitsopoulos; Hjalmar Flygt; Anders Holtz; Niklas Marklund
Journal:  Spinal Cord       Date:  2018-03-27       Impact factor: 2.772

4.  Cell-type specific expression of constitutively-active Rheb promotes regeneration of bulbospinal respiratory axons following cervical SCI.

Authors:  Mark W Urban; Biswarup Ghosh; Laura R Strojny; Cole G Block; Sara M Blazejewski; Megan C Wright; George M Smith; Angelo C Lepore
Journal:  Exp Neurol       Date:  2018-02-14       Impact factor: 5.330

5.  Thrombospondin-1 modified bone marrow mesenchymal stem cells (BMSCs) promote neurite outgrowth and functional recovery in rats with spinal cord injury.

Authors:  Yujie Pu; Ke Meng; Chuanlong Gu; Linlin Wang; Xiaoming Zhang
Journal:  Oncotarget       Date:  2017-10-24

6.  α-Tubulin Acetyltransferase Is a Novel Target Mediating Neurite Growth Inhibitory Effects of Chondroitin Sulfate Proteoglycans and Myelin-Associated Glycoprotein.

Authors:  Victor S C Wong; Cristina Picci; Michelle Swift; Max Levinson; Dianna Willis; Brett Langley
Journal:  eNeuro       Date:  2018-02-28

7.  Neural crest stem cells protect spinal cord neurons from excitotoxic damage and inhibit glial activation by secretion of brain-derived neurotrophic factor.

Authors:  Nikos Schizas; N König; B Andersson; S Vasylovska; J Hoeber; E N Kozlova; N P Hailer
Journal:  Cell Tissue Res       Date:  2018-03-07       Impact factor: 5.249

Review 8.  Lower extremity outcome measures: considerations for clinical trials in spinal cord injury.

Authors:  Marc Bolliger; Andrew R Blight; Edelle C Field-Fote; Kristin Musselman; Serge Rossignol; Dorothy Barthélemy; Laurent Bouyer; Milos R Popovic; Jan M Schwab; Michael L Boninger; Keith E Tansey; Giorgio Scivoletto; Naomi Kleitman; Linda A T Jones; Dany H Gagnon; Sylvie Nadeau; Dirk Haupt; Lea Awai; Chris S Easthope; Björn Zörner; Ruediger Rupp; Dan Lammertse; Armin Curt; John Steeves
Journal:  Spinal Cord       Date:  2018-04-27       Impact factor: 2.772

9.  Inclusive Trial Designs in Acute Spinal Cord Injuries: Prediction-Based Stratification of Clinical Walking Outcome and Projected Enrolment Frequencies.

Authors:  Adrian Cathomen; Laura Sirucek; Tim Killeen; Rainer Abel; Doris Maier; Norbert Weidner; Rüdiger Rupp; Torsten Hothorn; John D Steeves; Armin Curt; Marc Bolliger
Journal:  Neurorehabil Neural Repair       Date:  2022-02-14       Impact factor: 3.919

10.  Acellularized spinal cord scaffolds incorporating bpV(pic)/PLGA microspheres promote axonal regeneration and functional recovery after spinal cord injury.

Authors:  Jia Liu; Kai Li; Ke Huang; Chengliang Yang; Zhipeng Huang; Xingchang Zhao; Shiqiang Song; Taisen Pang; Jing Zhou; Yuhai Wang; Chong Wang; Yujin Tang
Journal:  RSC Adv       Date:  2020-05-18       Impact factor: 4.036

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.